Genpact Limited (NYSE:G) Plans Quarterly Dividend of $0.17

Genpact Limited (NYSE:G) declared a quarterly dividend on Friday, June 6th, RTT News reports. Investors of record on Wednesday, June 18th will be given a dividend of 0.17 per share by the business services provider on Monday, June 30th. This represents a $0.68 annualized dividend and a yield of 1.58%.

Genpact has a payout ratio of 18.2% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Genpact to earn $3.49 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 19.5%.

Genpact Price Performance

NYSE G opened at $43.09 on Friday. The company has a market capitalization of $7.54 billion, a PE ratio of 15.17, a price-to-earnings-growth ratio of 1.84 and a beta of 0.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The business’s fifty day moving average is $45.98 and its 200 day moving average is $47.23. Genpact has a fifty-two week low of $30.38 and a fifty-two week high of $56.76.

Genpact (NYSE:G) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. Genpact’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.73 earnings per share. Sell-side analysts predict that Genpact will post 3.21 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently commented on G shares. Wall Street Zen upgraded Genpact from a “buy” rating to a “strong-buy” rating in a research report on Friday. Robert W. Baird lowered their price objective on Genpact from $56.00 to $50.00 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. Needham & Company LLC lowered their price objective on Genpact from $55.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, May 8th. Finally, Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $50.71.

Insider Buying and Selling

In other news, Director Nicholas C. Gangestad bought 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares of the company’s stock, valued at approximately $87,940. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is owned by company insiders.

Institutional Investors Weigh In On Genpact

Large investors have recently added to or reduced their stakes in the stock. Focus Partners Wealth grew its stake in Genpact by 10.3% in the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider’s stock worth $263,000 after purchasing an additional 488 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Genpact by 12.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider’s stock worth $25,776,000 after purchasing an additional 56,557 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Genpact by 20.8% in the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider’s stock worth $17,788,000 after purchasing an additional 60,887 shares in the last quarter. Amundi bought a new position in Genpact in the first quarter worth approximately $58,000. Finally, Royal Bank of Canada grew its stake in Genpact by 19.7% in the first quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider’s stock worth $6,131,000 after purchasing an additional 20,043 shares in the last quarter. 96.03% of the stock is owned by institutional investors.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.